Colds, Influenza, and the Novel Coronavirus: Can Vitamins, Zinc, and Supplements Really Prevent Illness or Shorten Its Course?

Evidence on Supplements for Colds: From Vitamins C and D to Zinc and β-Glucan

Bottom line

For the general population, no vitamin, mineral, or supplement has been reliably shown to both prevent and treat the common cold, influenza, and COVID-19. Some interventions may offer limited benefits, but the disease, timing of use, formulation, and quality of evidence must each be assessed separately. PMID: 23440782；PMID: 28202713；PMID: 42078593

First distinguish the conditions: the common cold, influenza, and COVID-19 are not the same question

“Respiratory tract infection” is a broad endpoint. A favorable study result cannot simply be interpreted as proof that an intervention prevents every kind of cold or influenza. A meta-analysis of vitamin D once found a lower risk of acute respiratory tract infection, but that endpoint alone cannot establish efficacy against both the common cold and influenza. Professor Lin’s warning that media reports had extrapolated too far is consistent with the actual limits of the literature. PMID: 28202713

Likewise, the effectiveness of seasonal influenza vaccines varies by year, population, virus type, vaccine, and study context. A single average derived from multiple years should not be treated as a fixed protection rate that applies to everyone. This variability does not mean the vaccines are ineffective: research continues to support their ability to reduce laboratory-confirmed influenza. PMID: 41893754

Vitamin C: regular supplementation must be distinguished from use after symptoms begin

The central distinction identified in Professor Lin’s original article remains valid. In the general community, regular supplementation has not clearly reduced the incidence of the common cold. It may modestly shorten illness duration and lessen symptom severity, but results are inconsistent when supplementation begins only after symptoms have appeared. Reducing these findings to either “fully effective” or “completely ineffective in every situation” misses the key distinction. PMID: 23440782

As for claims that vitamin C can prevent or treat coronavirus infection, the literature has since been updated. The original article’s observation that no coronavirus clinical studies were available reflected the evidence at the time. Meta-analyses of subsequent randomized COVID-19 trials are now available, but they have not established significant benefits for the main clinical outcomes. The evolution of the science therefore has not supported claims of effective prevention or treatment. PMID: 42078593

Someone may genuinely feel that they recovered faster after taking a supplement. That experience, however, cannot exclude natural recovery, fluctuations in symptoms, other measures used at the same time, or expectancy effects. This is why personal testimony cannot replace controlled research.

Zinc: it may shorten illness, but it is not unconditionally effective

Zinc is one of the easiest examples in this area to overstate. Subsequent reviews indicate that therapeutic zinc may shorten the duration of the common cold, broadly supporting Professor Lin’s account that it “may help.” The overall evidence, however, has been rated limited or very low in certainty, and results depend on dose, formulation, and study design. It cannot be rewritten as a stable or guaranteed effect. PMID: 38719213

Zinc also increases non-serious adverse effects such as nausea and unpleasant taste. Thus, “may shorten symptoms” does not mean that everyone should use it on their own. Existing reviews have not found an increase in serious adverse events, but tolerability remains part of the decision. PMID: 34728441

Regarding intranasal zinc and loss of smell, the systematic literature included on this page does not provide enough data to quantify a causal relationship directly. The appropriate classification is therefore insufficient evidence, not a categorical claim that safety or harm has been proven. PMID: 38719213

Applying an antiviral mechanism observed in cell culture directly to the human nasopharynx cannot prove that zinc prevents or treats COVID-19. The small number of clinical trials has not confirmed such a benefit either. PMID: 35217499

Vitamin D: observing a low level does not mean supplementation will treat disease

Lower blood vitamin D levels in patients may occur alongside their general health status, disease severity, lifestyle, or other factors. Such an association does not itself prove that vitamin D deficiency causes infection, severe illness, or death, nor does it directly establish that supplementation is effective. Pooled causal-inference studies do not support a definite causal effect on COVID-19 outcomes. PMID: 39449666

For the treatment of COVID-19, the literature has been updated: summaries of later randomized trials mean that the field can no longer be described as having “no research at all.” Some reviews report possible signals of benefit, while others find those signals insufficiently robust and conclude that more randomized trials are still needed. The most accurate statement is that efficacy has not been established. It would be inaccurate to recast a review of early evidence as though Professor Lin himself later changed his position. PMID: 40139702；PMID: 40584095

Nor should a fixed risk reduction be claimed for every adult with respect to acute respiratory tract infections. The overall pooled result coexists with subgroup signals for particular supplementation regimens. This warrants a cautious reading but does not guarantee prevention of the common cold. PMID: 35215468

β-Glucan and multivitamins: the existence of research does not validate advertising promises

Pooled results for yeast β-glucan suggest possible favorable signals for the incidence, duration, or symptoms of upper respiratory tract infections in healthy people. Professor Lin’s acknowledgment that “some studies suggest it may help” is consistent with the current literature. However, there are few studies, heterogeneity is high, and statistical measures cannot be converted directly into a fixed percentage benefit guaranteed to an individual. Precise, confident efficacy claims therefore remain an overextension. PMID: 33900466

When a multivitamin or mineral study measures immune markers such as bacterial killing or phagocytosis, the media cannot legitimately repackage it as a trial of clinical benefit for colds. The study in question also found no improvement in the measured immune markers, supporting Professor Lin’s objection to that extrapolation. PMID: 32823974

How to interpret “consistent with the literature,” “partly consistent,” “insufficient evidence,” and “literature updated”

“Consistent with the literature” means that the original claim is supported by the evidence currently included. “Partly consistent” means that the overall direction is reasonable, but overly absolute wording requires exceptions or uncertainty to be added. “Insufficient evidence” means neither that efficacy has been established nor that the claim has been disproven; the available data do not permit a conclusion. “Literature updated” means that new studies appeared after the original article’s period. This should be described as scientific progress, not retroactively attributed to Professor Lin as something he said at the time.

In practice, when encountering claims such as “boosts immunity,” “natural antiviral,” or a precise promise of benefit, first ask whether the participants were human, whether the disease studied was the same, whether the intervention was used regularly before illness or begun after onset, whether symptoms merely became slightly shorter or infections actually became less frequent, and whether the quality of evidence is adequate for everyday decisions. These questions offer a more evidence-based reading than an eye-catching headline alone.